GlassScriptPhysician profile
Scott B Elsbree
NPI 1548260086
$7,393.05
in general payments reported to CMS, 2019-2025
50 companies · $627 in 2025
The $627 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,342 · 2020: $919 · 2021: $1,235 · 2022: $1,168 · 2023: $1,206 · 2024: $896 · 2025: $627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,677 · Education: $52.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,677.42 |
| Education | $52.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $924.53 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $905.25 | 2019-2025 | Repatha, Otezla, Otezla |
| Abbvie INC. | $724.10 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $492.88 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $406.49 | 2019-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $398.52 | 2019-2025 | |
| Exact Sciences Corporation | $345.95 | 2023-2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $345.84 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $306.18 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $300.37 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $281.02 | 2019-2022 | |
| Glaxosmithkline, LLC. | $214.00 | 2019-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $148.72 | 2020-2024 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.71 | 2019-2025 | Jardiance |
| Aytu Biopharma, INC. | $136.16 | 2019-2020 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Elsbree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.